Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | ABT-700 |
Trade Name | |
Synonyms | h224G11|Telisotuzumab|ABT 700|ABT700 |
Drug Descriptions |
ABT-700 (h224G11) is a bivalent monoclonal antibody that targets c-MET and inhibits activation of downstream signaling, potentially decreasing the growth of MET amplified tumors (PMID: 23134362, PMID: 32127466). |
DrugClasses | MET Antibody 31 |
CAS Registry Number | 1781223-80-0 |
NCIT ID | C106262 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
ABT-700 | ABT-700 | 0 | 1 |